Edition:
United States

Profile: Unilife Corp (UNS.AX)

UNS.AX on Australia Stock Exchange

0.04AUD
24 Feb 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.04
Open
$0.04
Day's High
$0.04
Day's Low
$0.04
Volume
12,430
Avg. Vol
927,442
52-wk High
$0.22
52-wk Low
$0.04

Unilife Corporation is engaged in the designing, development and manufacturing of injectable drug delivery systems. The Company has a portfolio of product platforms, including pre-filled syringes, disposable and reusable auto-injectors, drug reconstitution delivery systems, ocular delivery systems, and other systems for the targeted delivery of injectable therapies. The majority of its products are designed for sale directly to pharmaceutical and biotechnology companies supplying them as drug-device combination products, pre-filled and ready for administration by end-users, such as health-care providers or patients. Its other products, such as reusable auto-injectors and certain systems for targeted drug delivery are designed either to be sold to pharmaceutical or biotechnology companies for use as combination products or to be sold directly to a health care provider or end user without having the device pre-filled by a pharmaceutical company.

Company Address

Unilife Corp

250 Cross Farm Ln
YORK   PA   17406-6200
P: +1717.3843400
F: +1302.6555049

Company Web Links